S&P 500$7,553.68
-0.74%
2m
DOW 30$50,687.07
-1.21%
2m
NASDAQ 100$30,571.24
-0.29%
2m
Russell 2000$287.67
-1.37%
2m
Russell 1000$411.83
-0.71%
2m
S&P 400$3,751.11
-0.10%
2m
S&P 600$1,681.95
-0.85%
2m

ADAGENE SP ADS (ADAG)

NASDAQ

$3.46$0.00 (0.00%)

Price as of Jun 03, 2026 4:20 PM EDT

$262.3M
Market Cap
82.11%
1-Year Change
Biotechnology
Industry

Annual

Quarterly

	12/31/2025	12/31/2024	12/31/2023	12/31/2022
Income Statement
Total Operating Revenue	7.7M +7,332.76%	103,204 -99.43%	18.1M +94.90%	9.3M -8.67%
Cost of Revenue	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Gross Profit	7.7M +7,332.76%	103,204 -99.43%	18.1M +94.90%	9.3M -8.67%
Sales and Marketing Expense	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Research and Development Expense	-22.0M -23.45%	-28.8M -21.45%	-36.6M -54.96%	-81.3M +19.44%
Depreciation and Amortization Expense	438,864 -39.30%	722,950 -26.23%	980,053 -14.48%	1.1M +1.86%
Total Operating Expenses	7.1M -2.72%	7.3M -16.14%	8.7M -26.96%	11.9M -17.77%
Operating Profit	-21.4M -40.37%	-36.0M +51.57%	-23.7M -71.74%	-83.9M +15.97%
Interest Income	2.3M -39.39%	3.8M -11.25%	4.3M +1,034.59%	377,501 +395.63%
Interest Expense	N/A N/A	N/A N/A	-1.1M +59.78%	-693,323 +90.60%
Interest Income and Expense and Net	2.3M -39.39%	3.8M +19.72%	3.2M +1,105.40%	-315,822 +9.81%
Total Nonoperating Income and Expense	323,988 -30.57%	466,620 -74.69%	1.8M -14.99%	2.2M +21.90%
Income before Taxes	-17.9M -46.45%	-33.4M +93.81%	-17.3M -78.30%	-79.5M +11.24%
Income Taxes	-297,860 +1,596.92%	-17,553 -101.04%	1.7M +268.45%	459,055 -73.02%
Extraordinary Items	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Net Income	-17.6M -47.32%	-33.4M +76.41%	-18.9M -76.31%	-80.0M +9.28%
Net Income from Continuing Operations Applicable to Common	-17.6M -47.32%	-33.4M +76.41%	-18.9M -76.31%	-80.0M +9.24%
Basic EPS and Net Income	-0.30 -49.15%	-0.59 +68.57%	-0.35 -76.35%	-1.48 +1.37%
Diluted EPS and Net Income	-0.30 -49.15%	-0.59 +68.57%	-0.35 -76.35%	-1.48 +1.37%
Basic Weighted Average Shares	59.0M +4.83%	56.3M +2.83%	54.7M +1.11%	54.1M +8.20%
Diluted Weighted Average Shares	59.0M +4.83%	56.3M +2.83%	54.7M +1.11%	54.1M +8.20%
Balance Sheet
Cash and Cash Equivalents	74.5M -12.53%	85.2M -22.50%	109.9M -23.53%	143.8M -17.57%
Short-Term Investments	0 N/A	0 N/A	N/A N/A	N/A N/A
Cash and Cash Equivalents and Short-Term Investments	74.5M -12.53%	85.2M -22.50%	109.9M -23.53%	143.8M -17.57%
Total Current Assets	77.4M -11.85%	87.8M -22.62%	113.4M -24.02%	149.3M -19.70%
Accumulated Depreciation	7.8M +7.47%	7.3M +8.84%	6.7M +13.52%	5.9M +11.03%
Property and Plant and Equipment and Net	717,374 -36.26%	1.1M -38.67%	1.8M -34.06%	2.8M -20.20%
Total Long-Term Assets	25,223 -69.01%	81,386 -4.12%	84,885 -22.53%	109,572 +58.17%
Total Assets	78.3M -12.33%	89.3M -22.86%	115.7M -24.06%	152.4M -19.58%
Income Taxes Payable	410,198 +7,691.04%	5,265 -90.04%	52,884 -96.89%	1.7M 0.00%
Total Short-Term Debt	5.0M -72.01%	17.8M +111.89%	8.4M -74.51%	32.9M +120.15%
Total Current Liabilities	25.2M -34.08%	38.2M +21.39%	31.5M -42.89%	55.1M +84.70%
Total Long-Term Debt	1.1M +172.72%	417,339 -96.92%	13.5M -4.29%	14.1M +372.84%
Total Long-Term Liabilities	1.4M +149.59%	559,643 +1,848.75%	28,718 0.00%	28,718 -69.48%
Total Liabilities	26.4M -31.96%	38.7M -14.22%	45.2M -34.83%	69.3M +110.33%
Retained Earnings	-328.8M +5.66%	-311.2M +12.03%	-277.8M +7.32%	-258.8M +44.72%
Total Stockholders Equity	35.3M -30.03%	50.5M -28.40%	70.6M -15.08%	83.1M -46.93%
Total Shares Outstanding	59.2M +0.59%	58.9M +6.78%	55.1M +2.00%	54.1M -0.97%
Cash Flow
Cash from Operating Activities	-15.7M -47.28%	-29.7M +4.38%	-28.5M -41.47%	-48.6M +11.97%
Capital Expenditures	17,053 -49.22%	33,580 -60.50%	85,012 -87.70%	690,938 -72.47%
Cash from Investing Activities	476,803 -57.05%	1.1M +1,535.09%	-77,356 -88.72%	-686,046 -72.67%
Dividends Paid	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Cash from Financing Activities	4.4M +17.94%	3.8M +170.23%	-5.4M -130.11%	17.8M -87.74%
Financials Ratio
Gross Margin	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Operating Margin	-279.48% -99.20%	-34,835.42% +26,498.86%	-130.97% -85.50%	-903.08% +26.98%
Return on Assets	-21.02% -35.53%	-32.61% +130.74%	-14.13% -69.79%	-46.78% -12.49%
Return on Equity	-41.01% -25.71%	-55.21% +123.86%	-24.66% -63.05%	-66.74% -69.37%
Revenue Growth	7,332.76% +7,474.78%	-99.43% -204.77%	94.90% +1,194.16%	-8.67% -100.64%
Current Ratio	3.07 +33.71%	2.30 -36.26%	3.61 +33.04%	2.71 -56.52%
Cash Ratio	2.96 +32.70%	2.23 -36.16%	3.49 +33.90%	2.61 -55.37%
Debt-to-Equity Ratio	0.17 -51.97%	0.36 +15.92%	0.31 -45.14%	0.57 +394.07%
Debt-to-Assets Ratio	0.08 -61.67%	0.20 +7.59%	0.19 -38.64%	0.31 +226.29%

Earnings & Revenue History

Debt-to-Assets

Cash Flow